Originally published 2017-11-09.

Juan Carlos Izpisua Belmonte
No, scientists did not create a half-human, half-pig animal. What a team at the Salk Institute in California reported in January 2017 was far smaller and more technical: they placed human stem cells into very early pig embryos, let those embryos grow inside sows for about four weeks, and then checked whether any human cells had survived and settled into developing tissue. Some had. Roughly one cell in every 100,000 in the resulting embryos was human, and none of the embryos were allowed to come to term.
That modest result still mattered. It was the first published evidence that human cells can take part, however weakly, in the early development of a large animal whose organs are close to ours in size. The long-term hope behind the work is to one day grow transplantable human organs inside animals, a goal that remains years away.
What the Salk team actually did
The study, led by Juan Carlos Izpisua Belmonte with first author Jun Wu and more than 40 collaborators, appeared in the journal Cell on 26 January 2017 under the title “Interspecies chimerism with mammalian pluripotent stem cells.” According to National Geographic, the project took about four years of trial and error.
The researchers worked with human pluripotent stem cells, cells that can in principle become almost any tissue in the body. They tested three versions of these cells, each at a slightly different stage of development, and injected them into pig blastocysts, the hollow ball of cells that forms a few days after fertilisation. The embryos were then transferred into adult pigs acting as surrogates.
After three to four weeks the embryos were removed and examined. National Geographic reported that 186 later-stage chimeric embryos survived to that point. In some, human cells had begun to specialise into precursors of different tissues. Timing turned out to be critical: the most “naive” human cells survived poorly, while slightly more developed cells did better.
Why the human share was so small
About one in 100,000 cells being human is a very low level of chimerism, and the Salk team said so openly. Pigs and humans last shared a common ancestor tens of millions of years ago, and their embryos develop at different speeds. A pig pregnancy lasts under four months; a human one lasts nine. Cells from one species may simply be out of step with the signals coming from the other.
The same paper offered a more encouraging comparison. When the team put rat stem cells into mouse embryos whose own genes for building a pancreas had been switched off with the gene-editing tool CRISPR, the mice grew a functioning rat-derived pancreas. Some of these mice even developed a gallbladder made of rat cells, an organ rats do not normally have. The mice were healthy and lived normal lifespans. That rodent work showed the basic strategy can succeed when the two species are close relatives.
Izpisua Belmonte described the result in the Salk press release as a way to learn about more than transplants: “This provides us with an important tool for studying species evolution, biology and disease.”
Chimera, hybrid and the Greek myth behind the word
Headlines in 2017 often called the embryos “human-pig hybrids”, but scientists avoid that word here. In a true hybrid, such as a mule, every cell carries genetic material from both parents’ species. In a chimera, each cell belongs to one species or the other; the two populations of cells simply live side by side in one body.
The name comes from Greek mythology. In Homer’s Iliad the Chimera is a fire-breathing monster from Lycia in Asia Minor, with the front of a lion, the body of a goat and a serpent for a tail. The hero Bellerophon, riding the winged horse Pegasus, was said to have killed it.
Biological chimeras also occur naturally. In humans, two fertilised eggs can occasionally fuse very early in pregnancy, producing one person with two sets of DNA. Most people with this condition never find out. A few have learned of it only when a maternity or paternity test gave a confusing result, as in the widely reported case of Lydia Fairchild in the United States.
The organ shortage that drives this research
The motivation is practical. National Geographic, citing U.S. figures at the time, reported that a new name was added to the national transplant waiting list every ten minutes and that 22 people on the list died each day without receiving an organ. Donor organs are scarce everywhere, and patients who receive one must take drugs for life to stop their immune system rejecting it.
There are two broad ways to make an animal carry human tissue. The first is to transplant an organ from one species into another, which runs straight into rejection. The second, used at Salk, is to introduce cells at the embryo stage so that the organ grows from the start inside the host. Combined with gene editing that empties a “slot” for one organ, this approach, called blastocyst complementation, could in theory produce an organ made of a patient’s own cells, grown from stem cells reprogrammed from their skin or blood.
That is the theory. In practice, any organ would also need human blood vessels and would have to be free of animal viruses before it could be used in a person.
The ethical questions
Research that mixes human and animal cells raises concerns that go beyond ordinary lab safety. The most common worry is that human cells might contribute to an animal’s brain or reproductive cells. Ending pregnancies early, before a nervous system has formed, is one of the main safeguards researchers use.
At the time of the Salk study, this kind of work was not eligible for U.S. federal funding. The National Institutes of Health had paused funding for it in 2015 while it reviewed the issues, so the Salk team relied on private donors. Other countries have since set their own rules. Japan, for example, approved a project in 2019 allowing human cells to be grown in animal embryos and carried for longer, and in 2021 a team that included Izpisua Belmonte reported studying human cells in monkey embryos, which reopened the debate.
Common myths are worth clearing up. These embryos were not conscious, did not look human, did not reproduce and were never born. The research also has not yet produced a single organ that a patient could receive.
What has happened since
Progress has been slow but real. In September 2023 a team led by Liangxue Lai of the Guangzhou Institutes of Biomedicine and Health reported in Cell Stem Cell that it had grown early-stage kidney structures containing human cells inside pig embryos that lacked two genes needed for kidney development. Removing the pig’s own kidney-building programme left room for the human cells.
The limits were clear. The blood vessels in those kidneys were still made of pig cells, so they could not be transplanted, and the pregnancies were ended at around 25 to 28 days, before a brain had formed. Even so, the study showed the strategy first tested at Salk could produce a recognisable organ structure rather than scattered cells.
In the meantime, a separate approach has moved faster: transplanting kidneys and hearts from gene-edited pigs directly into patients. Those organs are pig tissue modified to be less likely to trigger rejection, not human tissue grown in a pig, and both lines of research continue side by side.
In the video below, the Salk researchers explain their 2017 results in their own words.
For anyone following this field, the useful rule of thumb is to check three things in each new headline: how many human cells were found, how long the embryos developed, and whether anything was actually transplanted. Those details separate a genuine step forward from a dramatic name.
Sources: Salk Institute press release, 26 January 2017; National Geographic: Human-pig hybrid created in the lab, here are the facts (January 2017); Progress Educational Trust: Kidneys with human cells grown in pig embryos (2023); Wikipedia: Chimera (genetics). Embryo image credited to Juan Carlos Izpisua Belmonte / Salk Institute; video by the Salk Institute research team.

COMMENTS